ME News reported on December 23 (UTC+8) that the decentralized science (DeSci) ecological platform LAVO Protocol announced the signing of a strategic cooperation memorandum (Memorandum of Understanding) with the international investment company Almak Group, led by Dubai royal member Sheikh Ali Rashed Ali Saeed Al Maktoum. Both parties will jointly promote the construction of longevity medicine research infrastructure and deeply expand LAVO's 'biological bridging' ecosystem into the Middle East and Asian markets. It is reported that LAVO Protocol is the world's first execution layer that directly connects decentralized liquidity with physical biotechnology, encompassing exclusive ExoBiome technology and GMP-grade industrial manufacturing capabilities. The project is led by regenerative medicine expert Dr. Jac and exosome technology authority Dr. Anton Philip Battiade Giacomo. By tokenizing real-world biotechnology and launching the first flagship token $EXO, LAVO aims to leverage Web3 to empower biopharmaceutical research and development, significantly accelerating the commercialization process and global delivery of longevity therapies. (Source: ME)